Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by skyhigh123on Jun 20, 2018 11:42am

356 Views

Post# 28199075

Email from Fred - CMC Controls

Hi Ric,

We are working on implementing all that is required by the FDA. We'll provide an update on the exact status of this at the Q2 call scheduled for mi-August.

Cheers,

Fred

Bullboard Posts

How to trade on the stock market: A beginner’s guide